Pre-market · Regular session opens 9:30 AM ET
Last update: Jun 30, 2026, 3:54 AM ET
Alnylam Pharmaceuticals, Inc. (ALNY) — What Changed
$293.52+2.15 (+0.74%) vs yesterday's close
Jun 30, 2026 6:28 AM ET·NASDAQ Global Select·Pre-market·CEO: Yvonne L. Greenstreet·2,230 employees
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company primarily dedicated to the discovery, development, and commercialization of innovative therapeutic solutions leveraging ribonucleic acid in…
🔔Major Change Detected
Price Move
+0.74%
1-Day Change
Volume Confirmation
1.18x
vs 30D Average
Catalyst
Earnings Beat
Material / Earnings
Peer Context
In Line With Peers
No peer data
Signal Quality
Low
Confidence Score
59/100
BestStocks surfaces only meaningful changes—backed by price, volume, catalysts, and peer context—so you can focus on what matters.
1. What Changed Since Last Close
F›
New FilingMediumMedium
May 27
Alnylam Pharmaceuticals (ALNY) filed an 8-K on May 27, 2026, with no corresponding stock price movement on that date.
E›
Earnings BeatHighHigh
Apr 30
Alnylam Pharmaceuticals (ALNY) reported EPS of $1.51 versus the consensus estimate of $0.87, a 73.2% earnings surprise f
Showing 2 of 2 events
2. Change Timeline
| Date | Change | Price Reaction | Volume | Confidence ↓ |
|---|---|---|---|---|
| Apr 30 | EEarnings Beat | — | — | High |
| May 27 | FNew Filing | — | — | Medium |
Sort:
3. Why It Moved
1
Primary Catalyst
Earnings Beat
Alnylam Pharmaceuticals (ALNY) reported EPS of $1.51 versus the consensus estima
2
Supporting Evidence
- Alnylam Pharmaceuticals (ALNY) reported EPS of $1.51 versus the consen
3
Nature of Move
Sector-Wide Move
ALNY moved broadly in line with sector peers — consistent with a sector or macro-driven event.
4. Peer / Sector Confirmation
| Symbol | Today | 5D | Rel. Vol | |
|---|---|---|---|---|
| ALNY | +0.74% | — | 1.18x |
Sector-Wide Move. No peer data. ALNY moved broadly in line with sector peers — consistent with a sector or macro event.
5. SEC Filing Watch
May 27High
Material event — review for impact
Apr 30High
Material event — review for impact
Apr 30Medium
Quarterly financial results
Apr 6Low
Annual proxy — exec compensation & governance
Mar 4High
Material event — review for impact
View on SEC EDGAR →Source: filing_snapshots DB · past 120 days
6. Analyst Expectations
Consensus Target
$450.64
Median Target
$447.00
Upside to Target
+53.5%
vs $293.52
Analyst Activity — Last 90 Days
0
Upgrades
6
Maintains
0
Downgrades
Last Directional Actions
↑ Upgrade
Freedom Broker · Hold → Buy
Feb 17, 2026
↓ Downgrade
Jefferies · Buy → Hold
Mar 16, 2026
7. Bull vs Bear Thesis Shift
Bullish Factors
✓Earnings beat with positive market reaction
✓Positive 0.7% session move
Bearish Factors
✕New SEC filing — review for material disclosures
Net Thesis Change vs Yesterday
BearishNeutralBullish
Bullish Shift+33 / 100
8. What To Watch Next
| Date | Event | Impact | |
|---|---|---|---|
| Jul 30 | Earnings Release | High |
Confirmed dates from FMP
🔔
9. Set Alerts & Get Notified
Get notified when ALNY reports earnings, files an 8-K, receives an analyst upgrade, or sees unusual volume.
✓ Earnings alerts
✓ Filing alerts
✓ Volume spikes
✓ Analyst actions